Rationally designed nanovehicles to overcome cancer chemoresistance von Livney, Yoav D., Assaraf, Yehuda G.

Volltext

Taxanes in cancer treatment: Activity, chemoresistance and its overcoming von Mosca, Luciana, Ilari, Andrea, Fazi, Francesco, Assaraf, Yehuda G., Colotti, Gianni

Volltext

Antifolates in cancer therapy: Structure, activity and mechanisms of drug resistance von Gonen, Nitzan, Assaraf, Yehuda G

Volltext

The key roles of the lysine acetyltransferases KAT6A and KAT6B in physiology and pathology von Wiesel-Motiuk, Naama, Assaraf, Yehuda G.

Volltext

Targeted Nanomedicine for Cancer Therapeutics: Towards Precision Medicine Overcoming Drug Resistance von Bar-Zeev, Maya, Livney, Yoav D, Assaraf, Yehuda G

Volltext

Lysosomal accumulation of anticancer drugs triggers lysosomal exocytosis von Zhitomirsky, Benny, Assaraf, Yehuda G

Volltext

ZnT2 is an electroneutral proton-coupled vesicular antiporter displaying an apparent stoichiometry of two protons per zinc ion von Golan, Yarden, Alhadeff, Raphael, Warshel, Arieh, Assaraf, Yehuda G

Volltext

Nanomedicine to target multidrug resistant tumors von Lepeltier, Elise, Rijo, Patricia, Rizzolio, Flavio, Popovtzer, Rachela, Petrikaite, Vilma, Assaraf, Yehuda G., Passirani, Catherine

Volltext

Towards the overcoming of anticancer drug resistance mediated by p53 mutations von Cao, Xin, Hou, Jiayun, An, Quanlin, Assaraf, Yehuda G., Wang, Xiangdong

Volltext

Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance von Zhitomirsky, Benny, Assaraf, Yehuda G

Volltext

Phospholipids and cholesterol: Inducers of cancer multidrug resistance and therapeutic targets von Kopecka, Joanna, Trouillas, Patrick, Gašparović, Ana Čipak, Gazzano, Elena, Assaraf, Yehuda G., Riganti, Chiara

Volltext

Long non-coding RNA mediated drug resistance in breast cancer von Singh, Deepshikha, Assaraf, Yehuda G., Gacche, Rajesh N.

Volltext

Modulating ROS to overcome multidrug resistance in cancer von Cui, Qingbin, Wang, Jing-Quan, Assaraf, Yehuda G., Ren, Liang, Gupta, Pranav, Wei, Liuya, Ashby, Charles R., Yang, Dong-Hua, Chen, Zhe-Sheng

Volltext

The folate receptor as a rational therapeutic target for personalized cancer treatment von Assaraf, Yehuda G, Leamon, Christopher P, Reddy, Joseph A

Volltext

Surmounting cancer drug resistance: New insights from the perspective of N 6 -methyladenosine RNA modification von Li, Bowen, Jiang, Jingwen, Assaraf, Yehuda G, Xiao, Hengyi, Chen, Zhe-Sheng, Huang, Canhua

Volltext

Chemical molecular‐based approach to overcome multidrug resistance in cancer by targeting P‐glycoprotein (P‐gp) von Zhang, Hang, Xu, Haiwei, Ashby, Charles R., Assaraf, Yehuda G., Chen, Zhe‐Sheng, Liu, Hong‐Min

Volltext

Molecular basis and rationale for combining immune checkpoint inhibitors with chemotherapy in non-small cell lung cancer von Leonetti, Alessandro, Wever, Birgit, Mazzaschi, Giulia, Assaraf, Yehuda G., Rolfo, Christian, Quaini, Federico, Tiseo, Marcello, Giovannetti, Elisa

Volltext

The multi-factorial nature of clinical multidrug resistance in cancer von Assaraf, Yehuda G., Brozovic, Anamaria, Gonçalves, Ana Cristina, Jurkovicova, Dana, Linē, Aija, Machuqueiro, Miguel, Saponara, Simona, Sarmento-Ribeiro, Ana Bela, Xavier, Cristina P.R., Vasconcelos, M. Helena

Volltext

Structure and function of ABCG2-rich extracellular vesicles mediating multidrug resistance von Goler-Baron, Vicky, Assaraf, Yehuda G

Volltext

Molecular basis of antifolate resistance von Assaraf, Yehuda G

Volltext